Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Nov;58(6):416-422.
doi: 10.4111/icu.2017.58.6.416. Epub 2017 Oct 23.

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma

Jack Crozier  1 , Nathan Papa  1 , Marlon Perera  1 , Michael Stewart  2 , Jeremy Goad  2 , Shomik Sengupta  1   3 , Damien Bolton  1   3 , Nathan Lawrentschuk  1   3   4
Affiliations
Multicenter Study

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma

Jack Crozier et al. Investig Clin Urol. 2017 Nov.

Abstract

Purpose: To determine the oncological implications of increased nodal dissection in node-negative bladder cancer during radical cystectomy in a contemporary Australian series.

Materials and methods: We performed a multicenter retrospective study, including more than 40 surgeons across 5 sites over a 10-year period. We identified 353 patients with primary bladder cancer undergoing radical cystectomy. Extent of lymphadenectomy was defined as follows; limited pelvic lymph node dissection (PLND) (perivesical, pelvic, and obturator), standard PLND (internal and external iliac) and extended PLND (common iliac). Multivariable cox proportional hazards and logistic regression models were used to determine LNY effect on cancer-specific survival.

Results: Over the study period, the extent of dissection and lymph node yield increased considerably. In node-negative patients, lymph node yield (LNY) conferred a significantly improved cancer-specific survival. Compared to cases where LNY of 1 to 5 nodes were taken, the hazard ratio (HR) for 6 to 15 nodes harvested was 0.78 (95% confidence interval [CI], 0.43-1.39) and for greater than 15 nodes the HR was 0.31 (95% CI, 0.17-0.57), adjusted for age, sex, T stage, margin status, and year of surgery. The predicted probability of cancer-specific death within 2 years of cystectomy was 16% (95% CI, 13%-19%) with 10 nodes harvested, falling to 5.5% (95% CI, 0%-12%) with 30 nodes taken. Increasing harvest in all PLND templates conferred a survival benefit.

Conclusions: The findings of the current study highlight the improved oncological outcomes with increased LNY, irrespective of the dissection template. Further prospective research is needed to aid LND data interpretation.

Keywords: Lymph node excision; Neoplasm staging; Survival; Urinary bladder neoplasms.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Definitions of pelvic lymph node dissection templates. Limited pelvic lymph node dissection (PLND) (A), standard PLND (B), extended PLND (C), and superextended PLND (D).
Fig. 2
Fig. 2. Populations of highest dissection level over time.
Fig. 3
Fig. 3. Populations of number of nodes taken over time.
Fig. 4
Fig. 4. Kaplan-Meier plots of bladder cancer specific survival grouped by number of nodes harvested with log-rank test.
Fig. 5
Fig. 5. Predicted probability (red line) of bladder cancer death within 2 years of cystectomy and 95% confidence interval. Black dots are patients who died of bladder cancer and blue dots are patients alive at 2. One patient alive at 2 years with 68 nodes harvested not shown.
Fig. 6
Fig. 6. Predicted probability of bladder cancer death within 2 years of cystectomy versus number of nodes taken at each dissection level.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
    1. Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–792. - PubMed
    1. Patel MI, Bang A, Gillatt D, Smith DP. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study. BJU Int. 2015;116(Suppl 3):18–25. - PubMed
    1. Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Asia Pac J Clin Oncol. 2013;9:29–39. - PubMed
    1. Vartolomei MD, Kiss B, Vidal A, Burkhard F, Thalmann GN, Roth B. Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy. BJU Int. 2016;117:618–628. - PubMed

Publication types